CompoAtlas

HMS CONCEPT T-TIGEZ CAPSULE

HMS CONCEPT T-TIGEZ CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Lignosus rhinocerusLignosus rhinocerus[150 mg,550 mg]Not identified
Andrographis paniculataAndrographis paniculata[100 mg,550 mg]Not identified
Sambucus nigraSambucus nigra[50 mg,550 mg]Not identified
Cordyceps sinensisCordyceps sinensis[200 mg,550 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL22126184T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
HMS CONCEPT SDN. BHD.
Manufacturer
Esprit Care Sdn. Bhd.
Registration period starting
2022-12-19
Published validity end
2027-12-19

Original register data

View published fields and their variants
Active ingredients
Lignosus rhinocerus[150 mg,550 mg],Andrographis paniculata[100 mg,550 mg],Sambucus nigra[50 mg,550 mg],Cordyceps sinensis[200 mg,550 mg]
Valid until
2027-12-19
Registration date
2022-12-19
Published description
NATURAL PRODUCT
Licence holder
HMS CONCEPT SDN. BHD.
Producer
Esprit Care Sdn. Bhd.
Published name
HMS CONCEPT T-TIGEZ CAPSULE
Published reference
202210039037T
Registration number
MAL22126184T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL22126184T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Sambucus nigra
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “HMS CONCEPT T-TIGEZ CAPSULE”, https://compoatlas.com/en/supplements/malaysia/MAL22126184T-hms-concept-t-tigez-capsule, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line